"目录号: HY-13772
EpigeneticsTGF-beta/Smad-
Valrubicin (AD-32)可作用于膀胱癌。
PKC
相关产品
Staurosporine-Phorbol 12-myristate 13-acetate-PKC412-Go 6983-Chelerythrine Chloride-Sotrastaurin-Fasudil Hydrochloride-Enzastaurin-Ro 31-8220 mesylate-Bisindolylmaleimide I-CGP60474-Zoledronic acid monohydrate-Ingenol Mebutate-Ruboxistaurin hydrochloride-Verbascoside-
生物活性
Description
Valrubicin (AD-32) is a chemotherapy drug used to treat bladder cancer.Target: OthersValrubicin is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder.
Clinical Trial
NCT01316874
Endo Pharmaceuticals
Carcinoma in Situ-Bladder Cancer
November 1993
Phase 2-Phase 3
NCT01606345
H. Lee Moffitt Cancer Center and Research Institute-Endo Pharmaceuticals
Urothelial Carcinoma
July 2012
Phase 1
NCT00003725
Anthra Pharmaceuticals-National Cancer Institute (NCI)
Bladder Cancer
December 1996
Phase 3
NCT00003129
Eastern Cooperative Oncology Group-National Cancer Institute (NCI)
Bladder Cancer
July 1998
Phase 2
NCT00003759
Anthra Pharmaceuticals-National Cancer Institute (NCI)
Bladder Cancer
November 1998
Phase 2
View MoreCollapse
References
[1].http://en.wikipedia.org/wiki/Valrubicin